| |SEPTEMBER 20244The pharma contract manufacturing market in India is growing at a healthy rate due to various reasons. There is a growing need for efficient manufacturing services, a factor driven by global pharmaceutical companies' intention to outsource the manufacturing of their products to cheaper markets. A skilled labor force, a robust and growing pharmaceutical industry in India has made contract manufacturing a preferred business model that is cost efficient, scalable and of high quality. India is well equipped with the regulatory compliances that are at par with the international standards which has further strengthened its position in the global contract manufacturing market. Because the country conforms to GMP and can meet the highly demanding standards of markets like the US and Europe, the country has become a reliable outsourcing partner to pharma majors. This has paved way to high demand for Indian contract manufacturers especially in APIs, generics and biologic products. ents in various sectors are driving the market's growth. The increasing investment in the infrastructure and technology also support the growth of the Indian pharma contract manufacturing market. To meet the increasing demand for quality pharmaceutical products, firms are putting their resources in modern production facilities, tools, automation and digitalization. Also, the increase in the number of new and complex drug formulations and the shift towards specialty drugs has presented new areas of growth for the contract manufacturers. Moreover, the favourable policies of the Indian government such as incentives to the pharma sector and the `Make in India' campaign have made both domestic as well as global companies to enter the contract manufacturing segment. Therefore, the market is predicted to remain on the rise with India further strengthening its place in the global pharma contract manufacturing in the future years. Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies from this sector that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback & suggestions. Sudhakar SinghManaging Editoreditor@indiapharmaoutlook.comVol 2 · Issue 3 - 8 · September, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial Team Nalini Brahmanapalli Viswanathan A DesignerV Hari PriyaSuanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Biz Print Media Pvt. Ltd. and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Driving Pharma Innovation
< Page 3 | Page 5 >